GlaxoSmithKline Intellectual Property Development Limited
发明人:
Niall Andrew Anderson,Nicholas Paul Barton,Sebastien Andre Campos,Edward Paul Cannons,Anthony William James Cooper,Kenneth David Down,Kevin James Doyle,Julie Nicole Hamblin,Graham George Adam Inglis,A
申请号：
US16572917
公开号：
US10793559B2
申请日:
2019.09.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I):and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
